Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy
Neurol 68:1249-1250,1245, Liow,K.,et al, 2007
Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999
When is Thrombolysis Justified in Patients with Acute Stroke? A Bioethical Perspective
Stroke 28:214-218, Furlan,A.J.&Kanoti,G., 1997
Outcomes of Stroke Patients in Medicare Fee for Service and Managed Care
JAMA 278:119-124, 1611997., Retchin,S.M.,et al, 1997
Quality of Neurological Care, Balancing Cost Control and Ethics
Arch Neurol 54:1341-1345, Bernat,J.L., 1997
The COVID-19 Pandemic and the Ethical Duties of the Neurologist
Neurol 95:167-172, Rubin, M.A.,et al, 2020
End of Life
Neurol 93:729-734, Masdeu, J.C.,et al, 2019
Ethical, Palliative, and Policy Considerations in Disorders of Consciousness
Neurol 91:471-475, Fins, J.J. & Bernat, J.L., 2018
Legal and Ethical Implications in the Evaluation and Management of Sports-Related Concussion
Neurol 83:352-359, Kirschen, M.P.,et al, 2014
An Update on Brain Death Criteria A Simple Algorithm with Complex Questions
The Neurologist 17-237-240, Scripko, P.D.,et al, 2011
Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older Adults
JAMA 303:1259-1265, 1309, Deyo,R.A., et al, 2010
Responding to Requests from Adult Patients for Neuroenhancements
Neurol 73:1406-1412, Larriviere,D.,et al, 2009
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
Position Statement Regarding the Use of Embryonic and Adult Human Stem Cells in Biomedical Research
Neurol 64:1679-1680,1675, American academy of Neurology and American Neurological Association, 2005
End-of-Life Care,A Survey of US Neurologists' Attitudes, Behavior, and Knowledge
Neurol 53:284-293, Carver,A.C.,et al, 1999
Tube Feeding in Patients with Advanced Dementia,A Review of the Evidence
JAMA 282:1365-1370, Finucane,T.E.,et al, 1999
Assisted Suicide
Euthanasia, and the Neurologist, The Ethics and Humanities Subcom of AAN, Neurol 50:596-59898., , 1998
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Attitudes of US Neurologists Concerning the Ethical Dimensions of Managed Care
Neurol 49:4-13, Bernat,J.L.,et al, 1997
Managed Care and Neurologists:Ethical Considerations
Ethics & Humanities Subcomm of Practice Comm of AAN, Neurol 49:321-32297., , 1997
Agreement on Disease-Specific Criteria for Do-Not-Resuscitate Orders in Acute Stroke
Stroke 27:232-237, Alexandrov,A.V.,et al, 1996
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Do-Not-Resuscitate Orders in Acute Stroke
Neurol 45:634-640, 6151995., Alexandrov,A.V.,et al, 1995
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
Assessment of Neurological Prognosis in Comatose Survivors of Cardiac Arrest
Lancet 343:1055-1059, Edgren,E.,et al, 1994
The Neurogenetic Genie:Testing for Huntington's Disease Mutation
Neurol 44:1369-1373, 1533-15361994., Hersch,S.,et al, 1994
The Older Driver, Clinical Assessment and Injury Prevention
Arch Int Med 152:735-740, Underwood,M., 1992